Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lax 510(k) Labeling Rules Alleged By Citizen Petition Citing Lumenis Device

This article was originally published in The Gray Sheet

Executive Summary

Labeling for 510(k)-cleared devices should include a notice informing consumers that FDA sign-off is based on applicant claims not verified by the agency, according to an Oct. 4 citizen petition

You may also be interested in...



ClearLight Acne Treatment DTC Advertising Will Follow More Laser Placement

Lumenis plans to launch a direct-to-consumer advertising campaign by the first quarter of 2003 in support of its ClearLight laser acne treatment system, which received FDA 510(k) clearance on Aug. 19

ESC Medical $203 Mil. Deal Ensures Coherent Ophthalmic Laser Portfolio

ESC Medical Systems' $203 mil. purchase of Coherent Medical Group gives it an entry into the high-growth ophthalmic laser market and strengthens the Israeli firm's presence in the U.S.

Finance Watch: Silverback, Kinnate, Sigilon Launch December’s First IPOs

Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.

UsernamePublicRestriction

Register

LL1134940

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel